• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALA
Click for more information
0.00% 11.5¢

AROVELLA THERAPEUTICS LIMITED

Market Cap $120.7M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ALA
Ann: EGM Company Presentation 		25/05/24 3 1.3K
25/05/24 Last post  Paulie Comments Created with Sketch.  3  Views Created with Sketch.  1.3K 
ALA
Ann: Notification regarding unquoted securities - ALA 		24/05/24 0 223
24/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  223 
ALA
Ann: Notification regarding unquoted securities - ALA 		24/05/24 0 151
24/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  151 
ALA
Ann: Results of Meeting 		23/05/24 0 266
23/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  266 
ALA
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		23/05/24 3 2.2K
23/05/24 Last post  standalone Comments Created with Sketch.  3  Views Created with Sketch.  2.2K 
ALA
Arovella Potential Future State Deals 		16/05/24 0 544
16/05/24 Last post  Kelvin8r Comments Created with Sketch.  0  Views Created with Sketch.  544 
ALA
Arovella 		15/05/24 6 3.0K
15/05/24 Last post  nchiwla Comments Created with Sketch.  6  Views Created with Sketch.  3.0K 
ALA
Ann: Updated Share Trading Policy 		01/05/24 0 574
01/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  574 

See All Discussions arrow Created with Sketch.

Timeline

Notification regarding unquoted securities - ALA
24 May 17:16
 
Notification regarding unquoted securities - ALA
24 May 16:44
 
Results of Meeting
23 May 15:51
 
EGM Company Presentation
23 May 10:54
 
Updated Share Trading Policy
01 May 11:38
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 09:51
 
View More arrow Created with Sketch.

Featured News

NEWS Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
right-arrow Created with Sketch.
SLS Historical prospects impress Solstice, with 25% copper and significant anomaly
right-arrow Created with Sketch.
YRL Yandal lines up prime gold targets at Ironstone Well-Barwidgee
right-arrow Created with Sketch.
NEWS The Telstra twist - What the job cuts decision mean for investors?
right-arrow Created with Sketch.
DY6 DY6 Metals (ASX:DY6) shares soar as company flags historical rare earth hits
right-arrow Created with Sketch.
ETM This ASX stock could sue Greenland's government for 4x its annual GDP
right-arrow Created with Sketch.

(20min delay)
Last
11.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $120.7M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
6 391319 11.5¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 26 1
View Market Depth
Last trade - 09.42am 28/05/2024 (20 minute delay) ?
ALA (ASX) Chart

Top Stories

Beamtree score $3.6M contract to expand hospital technology into Saudi Arabia

Beamtree Holdings Ltd has achieved a $3.6 million contract which will see it expand its AI technology into hospitals in Saudi Arabia.
Bailador invests in Updoc digital healthcare platform Bailador Technology Investments (ASX:BTI) has announced a $20million investment in Venture Startups International (Updoc).
Market Open: Australian stocks to edge up following Europe's rates cut hopes Australian stocks are set to rise slightly on Tuesday, following the trend in Europe as US Markets were away for the Memorial Day holiday.
PainCheck receives European patent for pain assessment technology PainCheck®, developer of the world’s first smartphone-based pain assessment and monitoring application, has been granted a patent in 20 European nations.
Market Close: ASX edges up with mostly smiles on green dials The ASX200 closed the day up 0.8%.All sectors bar one finished in the green. Real-estate lead the way, up 1.8%, tele-communications and staples followed, both gaining around 1.3%.The energy sector was the only sector to fall short, down 0.2%In the greenSayona Mining (ASX:SYA) gained 4.75% after i...

Featured News

TLM Talisman expands Rip n Tear with lead grading 7.4% and silver at 59.2g/t in NSW
right-arrow Created with Sketch.
ARU More, more, more: Arafura eyes another US$300M in funding for flagship
right-arrow Created with Sketch.
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
right-arrow Created with Sketch.
BCA Rock chips of more than 58% manganese guide Black Canyon's future drilling at Wandanya
right-arrow Created with Sketch.
PLY PlaySide to take gamers back to Westeros with new PC title
right-arrow Created with Sketch.
NEWS Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.